Carmot Therapeutics, Inc.

📍 Berkeley, United States🗓 Founded 2008👥 62 employees💰 Last funded Jul 2022
Biotechnology Research🌐 carmot-therapeutics.us
Website LinkedIn
Carmot Therapeutics is a clinical-stage biotechnology company that is focused on the discovery and development of disease-modifying therapies for people living with metabolic diseases including obesity and diabetes. We are utilizing Chemotype Evolution, a pioneering drug discovery platform, to identify novel incretin receptor signaling targets to develop a broad pipeline of therapeutics that have the potential to produce significant weight loss and improved glycemic control. We have three clinical candidates: CT-388, CT-868 and CT-996.
2
Total investors
0
Early stage
0
Mid stage
1
Late stage
2008
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Hong Kong SAR
1
United States
1
Frequently asked questions
Who invested in Carmot Therapeutics, Inc.?
Carmot Therapeutics, Inc. has 2 investors on record on gritt.io and 1 late-stage investors.
When did Carmot Therapeutics, Inc. last raise funding?
The most recent investment in Carmot Therapeutics, Inc. recorded on gritt.io was in July 2022.
When was Carmot Therapeutics, Inc. founded?
Carmot Therapeutics, Inc. was founded in 2008.
What industry is Carmot Therapeutics, Inc. in?
Carmot Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Carmot Therapeutics, Inc. based?
Carmot Therapeutics, Inc. is headquartered in Berkeley, United States.